开立医疗(300633.SZ):3名股东拟合计减持不超535万股
格隆汇6月1日丨开立医疗(300633.SZ)公布,持有公司股份约2217.44万股(占公司总股本比例5.46%)的股东黄奕波,计划以大宗交易(优先)、集中竞价等方式减持公司股份不超过250万股(占公司总股本比例0.62%),其中以大宗交易方式进行减持的将于减持计划公告之日起3个交易日之后的6个月内进行(2020年6月5日至2020年12月4日,法律法规规定不能进行减持的时间除外);其中以集中竞价交易方式进行减持的将于减持计划公告之日起15个交易日之后的6个月内进行(2020年6月23日至2020年12月22日,法律法规规定不能进行减持的时间除外)。
持有公司股份1845.51万股(占公司总股本比例4.55%)的股东周文平,计划以大宗交易(优先)、集中竞价等方式减持公司股份不超过250万股(占公司总股本比例0.62%),其中以大宗交易方式进行减持的将于减持计划公告之日起3个交易日之后的6个月内进行(2020年6月5日至2020年12月4日,法律法规规定不能进行减持的时间除外);其中以集中竞价交易方式进行减持的将于减持计划公告之日起15个交易日之后的6个月内进行(2020年6月23日至2020年12月22日,法律法规规定不能进行减持的时间除外)。
持有公司股份750万股(占公司总股本比例1.85%)的股东刘映芳,计划以大宗交易(优先)、集中竞价等方式减持公司股份不超过35万股(占公司总股本比例0.09%),其中以大宗交易方式进行减持的将于减持计划公告之日起3个交易日之后的6个月内进行(2020年6月5日至2020年12月4日,法律法规规定不能进行减持的时间除外);其中以集中竞价交易方式进行减持的将于减持计划公告之日起15个交易日之后的6个月内进行(2020年6月23日至2020年12月22日,法律法规规定不能进行减持的时间除外)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.